XML 67 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of Cash Flows - USD ($)
 2 Months Ended 5 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2021
Sep. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:        
Net Income (Loss) $ (11,579) $ (307,949) $ 152,167 $ 53,884
Adjustments to reconcile net loss to net cash used in operating activities:        
Interest income from Trust Account (1,349) (696,180) (1,348,596)
Changes in operating assets and liabilities:        
Accounts payable 11,579 11,579  
Prepaid expenses (7,505) (182,442) (135,550)
Accrued expenses 43,871 (27,834) 642,324
Other payables 20,000 90,000 120,000
Net cash used in operating activities (241,353) (664,289) (667,938)
Cash flows from investing activities:        
Investment of cash in Trust Account (116,725,000)
Net cash used in investing activities (116,725,000)
Cash flows from financing activities:        
Proceeds from issuance of Class B ordinary shares to Sponsor 25,000  
Payment of Offering Costs (303,020)  
Proceeds from sale of Units, net of underwriting discount paid 112,725,000  
Proceeds from sale of Private Placement units 5,280,750  
Payment of promissory note to related party (22,197)  
Payment of Accrued Expenses (23,453)  
Net cash provided by financing activities 117,682,080
Net change in cash 715,727 (664,289) (667,938)
Cash at the beginning of the period 715,727 715,727
Cash at the end of the period 715,727 51,438 47,789
Supplemental disclosure of non-cash financing activities:        
Deferred underwriting fee payable   4,025,000 4,025,000 4,025,000
Value of Class A ordinary shares subject to redemption   $ 116,725,000 $ 117,422,529 19,535,946
Extension loan receivable       $ 170,594
Deferred offering costs included in Promissory Note to Related Party 123,253      
Deferred offering costs paid by Sponsor for issuance of Class B Ordinary Shares 25,000      
Accrued offering costs $ 20,735